Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00334828
Status:
COMPLETED
Last Update Posted:
2017-07-25
First Post:
2006-06-06
Brief Title:
ACCESS A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
ACCESS A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis
Status:
COMPLETED
Status Verified Date:
2017-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare eritoran tetrasodium and placebo in patients with severe sepsis and to demonstrate a reduction of mortality from all causes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-005537-35 | EUDRACT_NUMBER | None | None |